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1027-192 The Assessment of Arterial Compliance Using 
Noninvasive Techniques: A Comparison of Radial and 
Ocular Measures of Arterial Pressure and Flow
Sinead M. Hughes, Lana J. Dixon, David R. Morgan, Rick Plumb, Andrew Gamble, 
Derrick Rea, Canice McGivern, Gary E. McVeigh, Queen's University, Belfast, United 
Kingdom
Background: Nitric Oxide (NO) plays a pivotal role in controlling the tone of arteries.Mod-
ulation of NO, by using the donor Glyceryl Trinitrate (GTN) or the inhibitor NG-Nitro-L-
arginine methyl ester (L-NAME) alters arterial tone.Changes in vascular tone have tradi-
tionally been assessed in terms of steady-state haemodynamics.These ignore the impor-
tance of the pulsatile element of the circulation.The latter can be derived from analysis of
the arterial pressure pulse contour recorded non-invasively. In this study we have com-
pared the use of radial tonometry with novel ocular measures of arterial pressure and
flow. Methods:10 healthy male volunteers had baseline radial artery pressure recorded
using the HDI/ PulsewaveTMCR-2000. Doppler ultrasound measures of flow in the ocular
arteries was made, using the ATLTM-HDI 3500 device. Ocular pressure was recorded
directly using the OBF Pneumotonometer.0.5 milligrams GTN was administered sublin-
gually. The above were then repeated after 3 minutes.A rest period of ten minutes
ensued after which L-NAME was infused intravenously at a dose of 0.25 mg/kg/min for 8
minutes. The dose was then increased to 0.5 mg/kg/min for a further 8 minutes. All mea-
sures were repeated after the dose increment and at the end. Results:No significant
change in Cardiac Output (CO) occured with GTN.Large arterial compliance was signifi-
cantly improved as was small arterial compliance. The radial and ocular waveshapes
changed significantly and consistently.CO was significantly decreased with L-NAME but
this was confounded by the reduction in heart rate. Small arterial compliance was signifi-
cantly reduced in a dose dependent fashion. A marked alteration in the pulse waveforms
was detected with L-NAME. These changes were found at both the radial and ocular
sites. Conclusions:Non-invasive measures of arterial tone can track changes in the vas-
culature in a sensitive manner. Pronounced changes occured in both the derived pulsa-
tile parameters and the waveshapes in response to changes in NO. Ocular measures of
arterial flow and pressure are comparable to radial studies and provide a unique and
novel method for assessing the microirculation non-invasively.
1027-193 Influence of Genetic and Nongenetic Factors on 
Endothelium-Dependent Microvascular Reactivity in the 
National Heart, Lung, and Blood Institute-Sponsored 
Women’s Ischemia Syndrome Evaluation (WISE)
Issam Zineh, Susan P. McGorray, Lacy L. Jernigan, Dennis M. McNamara, Daniel F. 
Pauly, C. Noel Bairey Merz, Carl J. Pepine, Julie A. Johnson, University of Florida, 
Gainesville, FL
Background: Endothelial dysfunction is a known contributor to coronary disease. It is
unclear what the additive contribution of traditional risk factors and genetic polymor-
phisms is on vascular reactivity in women with ischemic symptoms, and through what
mechanisms.
Methods: We studied 79 WISE women who underwent coronary angiography for sus-
pected ischemia. Average peak velocity ratio (APV-R) response to acetylcholine (Ach),
which produces endothelium-dependent vasodilation, was measured. Linear regression
was used to determine the joint effects of covariates on APV-R. Variables analyzed for
inclusion in the model were: age, race, β1-adrenergic receptor (AR), β2AR, and Gsα gen-
otypes, SBP, DBP, BMI, diabetes, hypertension, dyslipidemia, coronary artery disease,
CAD severity score, smoking status, ever oral contraceptive (OC) use, ever HRT use,
ACE inhibitor use, statin use, and menopausal status.
Results: The model of best fit (R2 = 0.34, <0.0001) included the non-genetic variables
history of hypertension (p=0.065), current smoker (p=0.0004), SBP (p=0.046), and ever
OC use (p=0.061). The β2AR Arg/Arg genotype at codon 16 (Arg16Arg) attenuated the
microvascular response to Ach (parameter estimate -0.396, p=0.0903). In white women
only, β2AR Gln27Gln genotype improved APV-R by 0.535, while β1AR Gly49 carrier sta-
tus diminished the response by 0.515, suggesting a race-by-genotype interaction. Poly-
morphisms at β1AR codon 389 and Gsα codon 131 had no effect.
Conclusion: Polymorphisms in the β2AR and codon 49 of the β1AR, and other non-
genetic factors are associated with endothelium-dependent microvascular reactivity in
women with ischemic symptoms. Consideration of these variables offers possible
insights into mechanisms of microvascular dysfunction. The risk conferred by these vari-
ables on clinical outcomes should be investigated in a broad population.
1027-194 Effects of Irbesartan and Lipoic Acid on Endothelial 
Function and Serum Inflammatory Markers in Patients 
With the Metabolic Syndrome
Srikanth Sola, Qasim Salar Mir, Sampath Parthasarathy, Bobby Khan, Emory University 
School of Medicine, Atlanta, GA
Background: The metabolic syndrome is associated with an increased incidence of
early or accelerated atherosclerosis. An increased activity of angiotensin II, induction of
the vascular oxidative state, and endothelial dysfunction are significant factors in the
pathogenesis of atherosclerosis. We wished to investigate the effects of irbesartan, an
angiotensin receptor blocker, and lipoic acid, an antioxidant, on endothelial function in
patients with the metabolic syndrome.
Methods: We enrolled 32 subjects that met the criteria for the metabolic syndrome into
the study. The subjects were randomized to placebo (Group A, n=8), 150mg/day irbe-
sartan (Group B, n=8), 1 g/day lipoic acid (Group C, n=8), or irbesartan and lipoic acid
(Group D, n=8) for 4 weeks. Serum levels of isoprostane and interleukin-6 (IL-6) were
measured. Endothelial dependent flow mediated vasodilation (FMD) was also deter-
mined.
Results: The FMD was significantly increased in Group B (39.6+7.3 to 66.6+10.0%,
p<0.005), Group C (42.5+6.4 to 61.6+8.0%, p<0.005), and Group D (40.8+8.1 to
72.2+8.4%, p<0.005). Serum levels of isoprostane were reduced in Group B (44.3+5.6 to
37.6+4.5 pg/ml, p<0.005) and Group D (46.1+6.5 to 36.0+5.3 pg/ml, p<0.005); no signifi-
cant changes were noted in Groups A or C. There was a reduction in serum IL-6 in Group
B (11.1+1.0 to 9.7+1.2 pg/ml, p<0.01), Group C (11.8+1.5 to 10.6+1.2 pg/ml, p<0.01),
and Group D (11.5+0.8 to 9.5+0.8 pg/ml, p<0.01). No significant changes in blood pres-
sure were noted in any of the study groups.
Conclusions: These findings suggest that administration of irbesartan and/or lipoic acid
to patients with the metabolic syndrome improves endothelial function and reduces pro-
inflammatory markers, factors which are implicated in the pathogenesis of atherosclero-
sis.
1027-195 Coronary Artery Disease Extent and Severity Is 
Associated With Pulse Wave Velocity, but Not Central 
Aortic Augmentation Index
Sarah A. Hope, Ian T. Meredith, Paul Antonis, David Adam, James D. Cameron, Monash 
Medical Centre, Melbourne, Australia, Monash University, Melbourne, Australia
Background: Although it is proposed that central aortic pressure waveform characteris-
tics, particularly augmentation index, influence cardiovascular disease progression and
may predict cardiovascular risk, nothing is known of the relationship between central
waveform characteristics and the severity and extent of coronary artery disease. We
tested the hypothesis that coronary artery disease extent and severity are associated
with central aortic pressure waveform characteristics in 40 patients (24 male).
Methods: Central aortic waveforms (2F Millar pressure transducer-tipped catheters)
were acquired at the time of coronary angiography for suspected native coronary artery
disease. The severity and extent of disease were assessed using 2 previously described
scoring systems (Modified Sullivan’s stenosis and extent scores). Relationships between
disease scores, aortic waveform characteristics, aorto-radial pulse wave velocity (PWV)
and subject demographic features and cardiovascular risk factors were assessed by
regression techniques.
Results: Both extent and severity scores were associated with increasing age and male
gender (P < 0.001), but no other risk factors. Both scores were independently associated
with PWV (P < 0.001), which entered a multiple regression model prior to age and gen-
der. This association was not related to mean, diastolic or systolic blood pressure. Nei-
ther score was associated with any central aortic waveform parameter, including
augmentation index, by either simple linear regression or multiple linear regression tech-
niques including heart rate and subject demographic features and cardiovascular risk
factors.
Conclusion: Aorto-radial PWV, but not central aortic augmentation index, is associated
with both the extent and severity of coronary artery disease.
1027-196 Tetrahydrobiopterin Corrects Escherichia Coli 
Endotoxin-Induced Endothelial Dysfunction
Friedrich Mittermayer, Johannes Pleiner, Georg Schaller, Stefan Zorn, Khodadad 
Namiranian, Stylianos Kapiotis, Raymond J. MacAllister, Michael Wolzt, University of 
Vienna, Vienna, Austria
Background. Acute inflammation causes endothelial dysfunction, which is partly medi-
ated by oxidant stress and inactivation of nitric oxide (NO). The contribution of depletion
of tetrahydrobiopterin (BH4), the cofactor required for NO generation, is unclear.
Methods. In this randomized, double blind, three-way cross-over study, forearm blood
flow (FBF) responses to acetylcholine (ACh) and glyceryltrinitrate (GTN) were measured
before and 4 hours after administration of Escherichia coli endotoxin (LPS, 20 IU/kg i.v.)
in 8 healthy males. The effect of intra-arterial BH4 (500 µg/min), placebo, or vitamin C
(24 mg/min) was studied 4 hours after LPS, respectively.
Results. ACh and GTN caused dose-dependent forearm vasodilation. LPS decreased
FBF responses to ACh by 23 ± 6 % (p<0.05), which was restored to baseline responsive-
ness by BH4 and vitamin C. FBF responses to GTN were not affected by BH4 or Vitamin
C. LPS increased leukocyte count, high sensitivity C-reactive protein, heart rate and body
temperature and decreased platelet count and vitamin C concentrations. Vitamin C
increased forearm plasma concentrations of BH4 from 17.3 ± 3.1 to 23.6 ± 4.2 nmol/l
after LPS (p<0.02).Conclusions. Impaired endothelial function during acute inflammation
can be restored by BH4 or vitamin C. Vitamin C may exert some of its effects by increas-
ing BH4 concentrations.
1027-197 Endothelial-Dependent Vasodilation Does Not Improve 
With the Atkins' Diet in Diabetic Subjects
Helene L. Glassberg, Joseph R. Libonati, III, Xiyu Zhang, Ranil DeSilva, Karin Sargrad, 
Alfred A. Bove, Guenther Boden, Temple University School of Medicine, Philadelphia, PA
Background: Vascular endothelial dysfunction has been associated with high-fat diets.
We tested the hypothesis that the Atkins’ diet will not improve endothelial function despite
potential improvement in metabolic parameters. Methods: Eight obese (BMI> 30) dia-
betic subjects were admitted to our Clinical Research Center for 21 days. Subjects
received their usual diet for 7 days, then received 14 days of the high fat/low-carbohy-
drate induction phase of the Atkins’ diet. Flow-mediated dilation was assessed (n=7)
before and after 2 weeks of the Atkins’ diet using brachial artery ultrasound to measure
artery diameter and blood velocity at baseline, during post-cuff occlusion reactive hyper-
emia (endothelium-dependent vasodilation (EDV)), and after 0.4 mg of sublingual nitro-
glycerin (endothelium-independent vasodilation (EIV)). Results: The 2-week Atkins’ diet
resulted in an average weight loss of 6.9 ± 2.4 lbs, p<0.05. There was no significant
change in total cholesterol, LDL or HDL cholesterol. Triglycerides decreased 25%, from
150 ± 21 to 113 ± 23 mg/dl (p=0.007). Fasting glucose fell 23%, from 140 ± 9 to 108 ± 5
mg/dl (p=0.004). Despite these favorable metabolic changes EDV remained unaltered.
